

BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves. Among its major competitors, BlueRock Therapeutics is ranked in 7th place for NPS while Intellia Therapeutics is 1st, and Novo Nordisk is 2nd.
BlueRock Therapeutics's Net Promoter Score (NPS) is a -67 with 0% Promoters, 33% Passives, and 67% Detractors. Net Promoter Score tracks whether BlueRock Therapeutics's customers would recommend using the product based on a scale of -100 to 100.
| 0% | Promoters |
|---|---|
| 33% | Passives |
| 67% | Detractors |
| Summary | Date | Score |
|---|---|---|
Mar 2022 0 | Mar 2022 | 0 |
Jan 2023 -50 | Jan 2023 | -50 |
Mar 2023 -66 | Mar 2023 | -66 |
BlueRock Therapeutics is ranked #4 for NPS among its competitors. Intellia Therapeutics and Novo Nordisk come in first and second, with Novartis Pharmaceuticals coming in at third.
![]() BlueRock Therapeutics | ![]() Novartis Pharmaceuticals | ![]() Novo Nordisk | ![]() Intellia Therapeutics | |
| Global Ranking | #- | #599 | #909 | #- |
| NPS | -67 | 23 | 38 | 49 |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | - | Neutral | - |
| Valuation Updated every 24 hours for public companies | - | - | $122.20B | $5.42B |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, BlueRock Therapeutics's NPS is rated right below eGenesis.
Customer Loyalty is a strong indicator of whether or not a customer will choose a brand repeatedly over a competitor that offers similar products/services.
55% of BlueRock Therapeutics users/customers answered "Yes" when asked: "Would you consider yourself a loyal user/customer?"
Sign Up to see the full customer demographics data and the people that answered "Yes" when asked "Would you consider yourself a loyal user/customer?"
Compared to its competitors, BlueRock Therapeutics's Customer Loyalty score is rated right above Ovid Therapeutics, and is preceded by bluebird bio.
| COMPANY | Customer Loyalty Score | |
|---|---|---|
![]() | Atara Biotherapeutics | 100% |
![]() | Novo Nordisk | 84% |
![]() | Novartis Pharmaceuticals | 80% |
![]() | Kite Pharma | 72% |
![]() | Intellia Therapeutics | 68% |
![]() | bluebird bio | 65% |
![]() | BlueRock Therapeutics | 55% |
![]() | Ovid Therapeutics | N/A |
![]() | Rubius Therapeutics | N/A |
![]() | eGenesis | N/A |
BlueRock Therapeutics has an overall Product Quality score of 1.5 out of 5 stars rated by its users and customers.
Sign Up to unlock BlueRock Therapeutics' overall Product Quality score rated by its users and customers.
BlueRock Therapeutics’s product quality score is a 1.5 out of 5 as rated by its users and customers.
Compared to its competitors, BlueRock Therapeutics's Product Quality score is rated right above Ovid Therapeutics, and is preceded by Intellia Therapeutics.
| COMPANY | Product Quality Score | |
|---|---|---|
![]() | bluebird bio | 4.2/5 |
![]() | Novo Nordisk | 4/5 |
![]() | Atara Biotherapeutics | 4/5 |
![]() | Novartis Pharmaceuticals | 3.9/5 |
![]() | Kite Pharma | 3.7/5 |
![]() | Intellia Therapeutics | 3.5/5 |
![]() | BlueRock Therapeutics | 1.5/5 |
![]() | Ovid Therapeutics | N/A |
![]() | Rubius Therapeutics | N/A |
![]() | eGenesis | N/A |
BlueRock Therapeutics has a value for money and ROI score of 1.5 out of 5 stars rated by its users and customers.
Sign Up to unlock BlueRock Therapeutics' overall ROI score rated by its users and customers.
Compared to its competitors, BlueRock Therapeutics's ROI score is rated right above Ovid Therapeutics, and is preceded by Atara Biotherapeutics.
| COMPANY | Pricing Score | |
|---|---|---|
![]() | bluebird bio | 4/5 |
![]() | Novo Nordisk | 3.8/5 |
![]() | Novartis Pharmaceuticals | 3.8/5 |
![]() | Kite Pharma | 3.6/5 |
![]() | Intellia Therapeutics | 3.3/5 |
![]() | Atara Biotherapeutics | 2.2/5 |
![]() | BlueRock Therapeutics | 1.5/5 |
![]() | Ovid Therapeutics | N/A |
![]() | Rubius Therapeutics | N/A |
![]() | eGenesis | N/A |
BlueRock Therapeutics has an overall Customer Satisfaction score of 34 rated by its users and customers.
Sign Up to see the full customer demographics data and the people that answered "How would you rate your overall satisfaction with the service you received?"
Customer Satisfaction Score (also known as CSAT), is a metric used to quantify how satisfied customers are with a company or brand’s products and services. The Customer Satisfaction Score is based on customers response to the question: “How would you rate your overall satisfaction with the service you received?” The score is calculated using the formula: (The total number answer of “Very Satisfied” and “Satisfied”) ÷ (The total response) x100, and it is generally displayed in percentages. Some of the main benefits of the CSAT for businesses are tracking retention, identifying happy customers and growing relationships, and gaining repeat business to build a sustainable brand.
Compared to its competitors, BlueRock Therapeutics's Customer Satisfaction score is rated right above Atara Biotherapeutics, and is preceded by Intellia Therapeutics.
| COMPANY | Customer Satisfaction (CSAT) Score | |
|---|---|---|
![]() | bluebird bio | 83% |
![]() | Novartis Pharmaceuticals | 80% |
![]() | Novo Nordisk | 76% |
![]() | Kite Pharma | 61% |
![]() | Intellia Therapeutics | 60% |
![]() | BlueRock Therapeutics | 34% |
![]() | Atara Biotherapeutics | 0% |
![]() | Ovid Therapeutics | 0% |
![]() | Rubius Therapeutics | 0% |
![]() | eGenesis | 0% |
BlueRock Therapeutics has an overall Customer Service score of 1.5 out of 5 stars rated by its users and customers.
Sign Up to unlock BlueRock Therapeutics' overall Customer Service score rated by its users and customers.
238 Main Street, Cambridge, MA 02142
https://www.bluerocktx.com
Compared to its competitors, BlueRock Therapeutics's Customer Service score is rated right above Ovid Therapeutics, and is preceded by Atara Biotherapeutics.
| COMPANY | Customer Service Score | |
|---|---|---|
![]() | Novartis Pharmaceuticals | 4/5 |
![]() | bluebird bio | 3.9/5 |
![]() | Intellia Therapeutics | 3.9/5 |
![]() | Novo Nordisk | 3.9/5 |
![]() | Kite Pharma | 3.7/5 |
![]() | Atara Biotherapeutics | 2.2/5 |
![]() | BlueRock Therapeutics | 1.5/5 |
![]() | Ovid Therapeutics | N/A |
![]() | Rubius Therapeutics | N/A |
![]() | eGenesis | N/A |
BlueRock Therapeutics has a 4.7/5 stars for its overall company culture rated by their employees

In the Top 5% of Similar Sized Companies on Comparably.

BlueRock Therapeutics scored a -67 for Net Promoter Score and a 70 for Employee Net Promoter Score. NPS gauges how likely a customer of BlueRock Therapeutics would recommend the brand to a friend. ENPS measures how likely BlueRock Therapeutics employees would recommend working at BlueRock Therapeutics to a friend.
| 0% | Promoters |
|---|---|
| 33% | Passive |
| 67% | Detractors |
| 75% | Promoters |
|---|---|
| 20% | Passive |
| 5% | Detractors |